Pastore Michael N, Kalia Yogeshvar N, Horstmann Michael, Roberts Michael S
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
Br J Pharmacol. 2015 May;172(9):2179-209. doi: 10.1111/bph.13059. Epub 2015 Mar 18.
Transdermal patches are now widely used as cosmetic, topical and transdermal delivery systems. These patches represent a key outcome from the growth in skin science, technology and expertise developed through trial and error, clinical observation and evidence-based studies that date back to the first existing human records. This review begins with the earliest topical therapies and traces topical delivery to the present-day transdermal patches, describing along the way the initial trials, devices and drug delivery systems that underpin current transdermal patches and their actives. This is followed by consideration of the evolution in the various patch designs and their limitations as well as requirements for actives to be used for transdermal delivery. The properties of and issues associated with the use of currently marketed products, such as variability, safety and regulatory aspects, are then described. The review concludes by examining future prospects for transdermal patches and drug delivery systems, such as the combination of active delivery systems with patches, minimally invasive microneedle patches and cutaneous solutions, including metered-dose systems.
透皮贴剂如今被广泛用作化妆品、局部用药及透皮给药系统。这些贴剂代表了皮肤科学、技术及专业知识发展的一项关键成果,其发展历程经历了反复试验、临床观察以及可追溯至现存最早人类记录的循证研究。本综述从最早的局部疗法开始,追溯局部给药至当今的透皮贴剂,沿途描述了支撑当前透皮贴剂及其活性成分的初始试验、装置和药物递送系统。接下来考虑各种贴剂设计的演变及其局限性,以及用于透皮给药的活性成分的要求。然后描述了当前市售产品使用中涉及的特性和问题,如变异性、安全性和监管方面。综述最后审视了透皮贴剂和药物递送系统的未来前景,如活性递送系统与贴剂的结合、微创微针贴剂和皮肤给药解决方案,包括定量给药系统。